CA1262400A - Process for the manufacture of glucosamine derivatives - Google Patents
Process for the manufacture of glucosamine derivativesInfo
- Publication number
- CA1262400A CA1262400A CA000267474A CA267474A CA1262400A CA 1262400 A CA1262400 A CA 1262400A CA 000267474 A CA000267474 A CA 000267474A CA 267474 A CA267474 A CA 267474A CA 1262400 A CA1262400 A CA 1262400A
- Authority
- CA
- Canada
- Prior art keywords
- denotes
- carbamoyl
- methyl
- benzyl
- lower alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
- C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
- C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
- C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH16042/75 | 1975-12-10 | ||
CH1604275A CH613709A5 (en) | 1975-12-10 | 1975-12-10 | Process for the preparation of glucosamine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1262400A true CA1262400A (en) | 1989-10-17 |
Family
ID=4414012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000267474A Expired CA1262400A (en) | 1975-12-10 | 1976-12-08 | Process for the manufacture of glucosamine derivatives |
Country Status (30)
Country | Link |
---|---|
JP (1) | JPS5273820A (no) |
AR (2) | AR224091A1 (no) |
AT (1) | AT365607B (no) |
AU (1) | AU508764B2 (no) |
BE (1) | BE849214A (no) |
CA (1) | CA1262400A (no) |
CH (2) | CH613709A5 (no) |
CS (4) | CS205027B2 (no) |
DD (1) | DD129781A5 (no) |
DE (1) | DE2655500A1 (no) |
DK (1) | DK154654C (no) |
ES (2) | ES454118A1 (no) |
FI (1) | FI64164C (no) |
FR (1) | FR2361902A1 (no) |
GB (1) | GB1570625A (no) |
GR (1) | GR61647B (no) |
HK (1) | HK32883A (no) |
HU (1) | HU177970B (no) |
IE (1) | IE44190B1 (no) |
IL (1) | IL51076A (no) |
MY (1) | MY8400123A (no) |
NL (1) | NL7613666A (no) |
NO (1) | NO144850C (no) |
NZ (1) | NZ182837A (no) |
PL (4) | PL112672B1 (no) |
PT (1) | PT65946B (no) |
SE (1) | SE445923B (no) |
SG (1) | SG11083G (no) |
SU (3) | SU660589A3 (no) |
ZA (1) | ZA767333B (no) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10717703B2 (en) | 2017-08-21 | 2020-07-21 | Celgene Corporation | Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4186194A (en) * | 1973-10-23 | 1980-01-29 | Agence Nationale De Valorisation De La Recherche (Anvar) | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
US4370265A (en) * | 1974-10-22 | 1983-01-25 | Agence Nationale De Valorisation | Water soluble agents effective as immunological adjuvants for stimulating in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
CH636887A5 (en) * | 1976-04-26 | 1983-06-30 | Syntex Inc | Process for the preparation of novel immunological adjuvant compounds |
DE2862107D1 (en) | 1977-12-02 | 1982-11-18 | Takeda Chemical Industries Ltd | Glucosamine-peptide derivatives and their pharmaceutical compositions |
CA1138436A (en) * | 1978-02-24 | 1982-12-28 | Gerhard Baschang | Process for the manufacture of novel antigens |
US4397844A (en) * | 1978-02-24 | 1983-08-09 | Ciba-Geigy Corporation | Antigen derivatives and processes for their preparation |
FR2420545A1 (fr) * | 1978-03-20 | 1979-10-19 | Anvar | Nouveaux esters de l'acide n-acetyl-muramyl-aminoacyl-glutamique ou des derives de substitution de celui-ci a proprietes anti-infectieuses et/ou d'adjuvants immunologiques |
FR2442241A2 (fr) * | 1978-03-20 | 1980-06-20 | Anvar | Nouveaux composes esters de muramyl-peptide, leur preparation et les compositions pharmaceutiques les contenant, notamment sous forme de liposomes |
FR2428051A1 (fr) * | 1978-06-05 | 1980-01-04 | Anvar | Nouveaux composes du type muramyl-peptide et medicaments les contenant |
FR2428050A1 (fr) * | 1978-06-05 | 1980-01-04 | Anvar | Oligomeres de composes du type muramyl-peptide et medicaments les contenant |
FR2446292A1 (fr) * | 1979-01-12 | 1980-08-08 | Anvar | Muramyl-peptides fixes sur polymeres peptidiques et medicaments les contenant |
US4256735A (en) | 1979-01-29 | 1981-03-17 | Merck & Co., Inc. | Immunologically active dipeptidyl saccharides and methods of preparation |
FR2449697A1 (fr) | 1979-02-20 | 1980-09-19 | Anvar | Nouveaux muramyl-peptides substitues sur un azote peptidique et medicaments les contenant |
JPS55111499A (en) * | 1979-02-21 | 1980-08-28 | Takeda Chem Ind Ltd | Glucosamine derivative and its preparation |
JPS5618996A (en) * | 1979-06-21 | 1981-02-23 | Dai Ichi Seiyaku Co Ltd | Muramyldipeptide derivative |
FI75578C (fi) | 1979-07-25 | 1988-07-11 | Ciba Geigy Ag | Analogifoerfarande foer framstaellning av farmakologiskt verkande lipofila fosfatidylmuramylpeptider. |
JPS5649396A (en) * | 1979-09-28 | 1981-05-02 | Dai Ichi Seiyaku Co Ltd | Novel muramyldipeptide derivative |
EP0026746B1 (de) * | 1979-10-02 | 1985-04-10 | Ciba-Geigy Ag | Kombinationspräparate zur Anwendung in einem Verfahren zur Steigerung der Wirkung von Antibiotika, antibiotische Präparate mit gesteigerter Wirksamkeit und Verfahren zu deren Herstellung |
US4409209A (en) * | 1979-10-12 | 1983-10-11 | Ciba-Geigy Corporation | Novel phosphorylmuramyl peptides and processes for the manufacture thereof |
FI803077A (fi) * | 1979-10-12 | 1981-04-13 | Ciba Geigy Ag | Foerfarande foer framstaellning av myramylpeptider |
US4406889A (en) * | 1980-02-15 | 1983-09-27 | Ciba-Geigy Corporation | Derivatives of aldohexoses, intermediates, processes for their manufacture, preparations containing such compounds, and their use |
US4368190A (en) * | 1980-04-17 | 1983-01-11 | Merck & Co., Inc. | Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation |
US4310514A (en) | 1980-05-05 | 1982-01-12 | Merck & Co., Inc. | Immunologically active dipeptidyl 5-0,6-0-acyl-2-amino-2-deoxy-D-glucofuranose derivatives and methods of preparation |
EP0056560A1 (de) * | 1981-01-19 | 1982-07-28 | Ciba-Geigy Ag | Antibiotische Präparate mit gesteigerter Wirksamkeit, Verfahren zu deren Herstellung und Verfahren zur Steigerung der antibiotischen Wirkung von Antibiotika |
GR78246B (no) * | 1981-01-23 | 1984-09-26 | Ciba Geigy Ag | |
JPS6042398A (ja) * | 1983-08-18 | 1985-03-06 | Toshiyuki Hamaoka | ムラミルジペプチド活性エステル誘導体 |
EP0541486A1 (de) * | 1991-11-07 | 1993-05-12 | Ciba-Geigy Ag | Polycyclische Konjugate |
US7838685B2 (en) | 2005-04-27 | 2010-11-23 | Shinji Takeoka | Cationic amino acid type lipid |
US10610564B2 (en) | 2015-02-26 | 2020-04-07 | Stc.Unm | IRGM and precision autophagy controls for antimicrobial and inflammatory disease states and methods of detection of autophagy |
WO2017098529A1 (en) | 2015-12-10 | 2017-06-15 | Bharat Biotech International Limited | Novel muramyl peptide derivative compound, synthesis and uses thereof |
EP3389643B1 (en) * | 2015-12-15 | 2023-05-03 | Bharat Biotech International Limited | Novel muramyl peptide derivative compound, synthesis and uses thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4186194A (en) * | 1973-10-23 | 1980-01-29 | Agence Nationale De Valorisation De La Recherche (Anvar) | Water soluble agents effective as immunological adjuvants for stimulating, in the host the immune response to various antigens and compositions, notably vaccines containing said water soluble agents |
-
1975
- 1975-12-10 CH CH1604275A patent/CH613709A5/xx not_active IP Right Cessation
-
1976
- 1976-12-08 SU SU762428152A patent/SU660589A3/ru active
- 1976-12-08 CA CA000267474A patent/CA1262400A/en not_active Expired
- 1976-12-08 DE DE19762655500 patent/DE2655500A1/de active Granted
- 1976-12-08 GR GR52361A patent/GR61647B/el unknown
- 1976-12-08 GB GB51228/76A patent/GB1570625A/en not_active Expired
- 1976-12-08 NL NL7613666A patent/NL7613666A/xx not_active Application Discontinuation
- 1976-12-09 SE SE7613851A patent/SE445923B/xx not_active IP Right Cessation
- 1976-12-09 FR FR7637091A patent/FR2361902A1/fr active Granted
- 1976-12-09 BE BE173091A patent/BE849214A/xx not_active IP Right Cessation
- 1976-12-09 IE IE2689/76A patent/IE44190B1/en not_active IP Right Cessation
- 1976-12-09 HU HU76CI1702A patent/HU177970B/hu unknown
- 1976-12-09 FI FI763541A patent/FI64164C/fi not_active IP Right Cessation
- 1976-12-09 NZ NZ182837A patent/NZ182837A/xx unknown
- 1976-12-09 DK DK552476A patent/DK154654C/da not_active IP Right Cessation
- 1976-12-09 CS CS768063A patent/CS205027B2/cs unknown
- 1976-12-09 DD DD7600196215A patent/DD129781A5/xx unknown
- 1976-12-09 AU AU20422/76A patent/AU508764B2/en not_active Expired
- 1976-12-09 CS CS768063A patent/CS205025B2/cs unknown
- 1976-12-09 PT PT65946A patent/PT65946B/pt unknown
- 1976-12-09 AT AT0909276A patent/AT365607B/de not_active IP Right Cessation
- 1976-12-09 IL IL51076A patent/IL51076A/xx unknown
- 1976-12-09 NO NO764191A patent/NO144850C/no unknown
- 1976-12-09 CS CS768063A patent/CS205026B2/cs unknown
- 1976-12-09 CS CS768063A patent/CS205028B2/cs unknown
- 1976-12-09 ZA ZA767333A patent/ZA767333B/xx unknown
- 1976-12-10 JP JP51147903A patent/JPS5273820A/ja active Granted
- 1976-12-10 PL PL1976210826A patent/PL112672B1/pl unknown
- 1976-12-10 AR AR265799A patent/AR224091A1/es active
- 1976-12-10 PL PL1976210827A patent/PL110787B1/pl unknown
- 1976-12-10 ES ES454118A patent/ES454118A1/es not_active Expired
- 1976-12-10 PL PL1976194291A patent/PL110353B1/pl not_active IP Right Cessation
- 1976-12-10 PL PL1976210828A patent/PL110794B1/pl unknown
-
1977
- 1977-09-08 SU SU772518658A patent/SU1060118A3/ru active
- 1977-09-08 SU SU772521659A patent/SU747430A3/ru active
- 1977-09-30 AR AR269405A patent/AR220686A1/es active
- 1977-12-28 ES ES465514A patent/ES465514A1/es not_active Expired
-
1978
- 1978-08-24 CH CH898378A patent/CH614718A5/xx not_active IP Right Cessation
-
1983
- 1983-03-14 SG SG110/83A patent/SG11083G/en unknown
- 1983-08-25 HK HK328/83A patent/HK32883A/xx unknown
-
1984
- 1984-12-30 MY MY123/84A patent/MY8400123A/xx unknown
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10717703B2 (en) | 2017-08-21 | 2020-07-21 | Celgene Corporation | Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate |
US11505522B2 (en) | 2017-08-21 | 2022-11-22 | Celgene Corporation | Processes for the preparation of (S)-tert-butyl 4,5- diamino-5-oxopentanoate |
US11912644B2 (en) | 2017-08-21 | 2024-02-27 | Celgene Corporation | Processes for the preparation of (S)-tert-butyl 4,5-diamino-5-oxopentanoate |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1262400A (en) | Process for the manufacture of glucosamine derivatives | |
CA1183525A (en) | Phosphorylmuramyl peptides and processes for the manufacture thereof | |
US4082736A (en) | Novel immunological adjuvant compounds and methods of preparation thereof | |
US4082735A (en) | Novel immunological adjuvant compounds and methods of preparation thereof | |
US4369178A (en) | Glucosamine peptide derivatives, their production and use | |
CA1185237A (en) | 6-deoxyglucosamine-peptide derivatives, their production and use | |
US4368190A (en) | Immunologically active dipeptidyl 4-O-,6-O-acyl-2-amino-2-deoxy-D-glucose derivatives and methods for their preparation | |
CA1175804A (en) | Immunologically active dipeptidyl 5-0, 6-0-acyl- 2- amino-2-deoxy-d-gluofuranose derivatives and methods of preparation | |
EP0074787A1 (en) | Renally active dipeptides | |
GB1571133A (en) | Immuniological adjuvant peptidoglycans compounds and methods of preparation thereof | |
US4256735A (en) | Immunologically active dipeptidyl saccharides and methods of preparation | |
GB2053232A (en) | Dipeptides their preparation and the medicaments in which they are present | |
US4391800A (en) | Immunologically active peptidyl disaccharides and methods of preparation | |
KR890002085B1 (ko) | 디히드로오로트산 유도체의 제조방법 | |
US4377570A (en) | Immunologically active dipeptidyl saccharides and methods of preparation | |
Zaoral et al. | Preparation and some biological properties of N-acetylmuramyl-alanyl-D-isoglutamine (MDP) analogues | |
CA1183528A (en) | Processes for the manufacture of novel glucose derivatives | |
PT95881B (pt) | Processo para a preparacao de derivados de pradimicina com accao anti-fungica e de composicoes farmaceuticas que os contem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |